Contract 75N95021P00063
Avista Pharma Solutions, Inc. · Department Of Health And Human Services · September 9, 2021
Avista Pharma Solutions, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 9, 2021 for $76,000 of work in pharmaceutical preparation manufacturing. Performance is in Durham, NC. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 29, 2021. If all options are exercised, the contract could reach $1.84 million.
Contract details
- PIID
- 75N95021P00063
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Durham, NC
- First action
- September 9, 2021
- Latest action
- September 29, 2021
Description
ACQUISITION OF CGMP-GRADE GS-441524 FOR THE TREATMENT OF COVID-19.
Modification timeline
-
September 29, 2021Mod P00004 · Supplemental Agreement For Work Within Scope$1.84M
-
September 9, 2021Mod P00003 · Supplemental Agreement For Work Within Scope$1.79M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Merck Sharp & Dohme Llc | Department Of Health And Human Services | March 27, 2026 | $361.34M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N95021P00063?
Contract 75N95021P00063 is a federal contract awarded to Avista Pharma Solutions, Inc. by Department Of Health And Human Services on September 9, 2021 for $76,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75N95021P00063?
Avista Pharma Solutions, Inc. won contract 75N95021P00063 from Department Of Health And Human Services.
How much is contract 75N95021P00063 worth?
Contract 75N95021P00063 has obligated $76,000 to date, with a total potential value of $1.84 million if all options are exercised.